Target intelligence / Profile preview

Immune modulation via regulatory T cell

Molecular classification
Transcription factor, Cytokine, Cell surface receptor, Enzyme
01

Overview

Regulatory T cells (Tregs) are a specialized subpopulation of CD4+ T lymphocytes that play a central role in maintaining immune homeostasis and self-tolerance. They actively suppress the activation and proliferation of other immune cells, thereby preventing autoimmune diseases, moderating chronic inflammation, and limiting excessive immune responses to pathogens or environmental insults. Tregs employ multiple mechanisms to modulate immune responses, including secretion of inhibitory cytokines, induction of apoptosis, cell-to-cell contact inhibition, and metabolic disruption. Understanding how to modulate regulatory T cell function has significant translational potential for treating autoimmunity, cancer, and other diseases.

Other names
Treg modulationRegulatory T cell suppressionTreg-mediated immunosuppression
02

Mechanism of action

Tregs employ multiple mechanisms to modulate immune responses including secretion of inhibitory cytokines (IL-10, TGF-β, IL-35), induction of apoptosis in effector immune cells (Granzyme B), cell-to-cell contact inhibition (CTLA‐4, TIGIT, LAG3), induction of immunosuppressive enzymes in dendritic cells (IDO), and generation of adenosine via CD39/CD73 pathway.

03

Biological functions

Immune responseImmune toleranceSuppression of immune cell activationMaintenance of immune homeostasisApoptosis inductionCytokine production
04

Disease associations

AutoimmunityInflammationTransplant rejectionCancerInfectionDiabetes mellitusAtherosclerosisNeurodegenerative diseaseWound healingAging-related tissue homeostasis disturbances
05

Safety considerations

Excessive immunosuppression leading to increased risk of infectionImpaired anti-tumor immunityOff-target effects of Treg-modulating therapiesPotential for instability or dysfunction of transferred Tregs
06

Interacting drugs

IL-2

5 more in the full profile.

07

Biomarkers

Foxp3CD25CD4CTLA-4GITRTIGITLAG3

Beyond the preview

Go deeper on Immune modulation via regulatory T cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune modulation via regulatory T cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call